Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2018-04-24 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2017年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an audit report and financial statements for the fiscal year 2017 of Guangzhou Yangpu Medical Technology Co., Ltd. It includes an auditor's opinion, basis for the opinion, key audit matters, management responsibilities, and detailed financial statements such as consolidated balance sheets, income statements, and cash flow statements. The presence of a formal auditor's report with audit opinion and detailed financial data confirms this is a standalone audit report and financial information, not a full annual report or just an announcement. The document length is substantial (15,000 characters) and contains actual financial data and analysis, not merely a reference or certification. Therefore, the document fits the category of Audit Report / Information (AR). FY 2017
2018-04-24 Chinese
第四届董事会第十三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 13th meeting of the 4th Board of Directors of Guangzhou Yangpu Medical Technology Co., Ltd. It includes approvals of the 2017 Annual Report, financial statements audited by an accounting firm, profit distribution plan, internal control self-assessment report, changes in accounting policies, asset impairment provisions, use of previously raised funds, and the 2018 Q1 report. The document repeatedly states that the full reports are available on the China Securities Regulatory Commission designated disclosure website (Giant Tide Information Network). The document is a formal board meeting resolution announcement, not the full annual report or quarterly report itself. It also mentions that these matters will be submitted to the shareholders' meeting for approval. The document length is about 4954 characters, which is relatively short and mainly summarizes approvals and references full reports elsewhere. This fits the pattern of a Regulatory Filing (RNS) rather than the full Annual Report (10-K) or Interim Report (IR).
2018-04-24 Chinese
关于2017年度日常关联交易完成情况及2018年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the completion of 2017 daily related party transactions and the forecast for 2018 daily related party transactions. It includes detailed financial figures about transactions with related parties, explanations for deviations from expected amounts, and approvals from the board and independent directors. The document is a regulatory announcement about related party transactions, which is a common disclosure for listed companies to inform shareholders and the market about ongoing related party dealings. It does not contain comprehensive financial statements or constitute a full financial report like an annual or interim report. It is not a voting result, management change, or earnings release. The document is more detailed than a simple notice but is primarily a regulatory disclosure about related party transactions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-04-24 Chinese
独立董事2017年度述职报告（谢石松）
Board/Management Information Classification · 95% confidence The document is an Independent Director's 2017 Annual Work Report for Guangzhou Yangpu Medical Technology Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions on company matters, committee work, investigations, investor protection efforts, training, and suggestions for the company. It is a narrative report on governance and oversight activities by an independent director rather than a financial report, audit report, or regulatory filing. It does not contain financial statements or earnings data, nor is it a brief announcement or proxy material. The content aligns with Board/Management Information (MANG) as it relates to board member duties and governance activities.
2018-04-24 Chinese
关于2017年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the 2017 annual profit distribution plan. It includes details about the profit distribution proposal, the board and supervisory committee meetings approving the plan, and the need for shareholder approval at the 2017 annual general meeting. The document does not contain full financial statements or comprehensive financial performance data but focuses on the dividend distribution plan and related approvals. The document length is short (1277 characters) and it is an announcement of a profit distribution plan rather than a full annual report or financial statement. This fits the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and details for shareholders.
2018-04-24 Chinese
关于公司及子公司收到政府补助的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding government subsidies received by the company and its subsidiaries during the period from January 1, 2018 to March 31, 2018. It details the amounts, sources, and accounting treatment of these subsidies. The document is relatively short (3043 characters) and primarily serves as a disclosure of government grants and their expected impact on profits. It does not contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not a certification, management change, or other specific filing type. The content fits best with a Regulatory Filing (RNS) as it is a regulatory announcement disclosing material information about government subsidies received, without constituting a full financial report or other specialized filing.
2018-04-24 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.